CEROW
CERo Therapeutics Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
−26.92%Price chart
May 19Jun 2Jun 5Jun 17Jul 9Aug 5Aug 20Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.4x
Market Cap
$3604.92
MomentumView details →
1D Return
−26.92%
YTD Return
−49.11%
RSI (14)
48.9
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.4x
Market Cap
$3604.92
RSI (14)
48.9
MomentumView details →
1D Return
−26.92%
YTD Return
−49.11%
Similar companies
Latest newsMore news →
CERO Therapeutics Holdings, Inc. signed a consolidated senior secured promissory note with SRX Global Inc. for up to $11,666,108.77, consolidating previous notes and providing additional advances, with interest at 10% per annum and maturity on October 15, 2026.4d agoSRX Global Inc. issued 3,579 shares of Series C Convertible Preferred Stock to an accredited investor for $2,862,500, paid via assignment of Convertible Grid Promissory Notes from CERO Therapeutics Holdings, Inc., in a private placement under Regulation D Rule 506(b).7d agoCero Therapeutics Holdings, Inc. entered into a Second Amended and Restated Convertible Grid Promissory Note due 2027, providing for maximum aggregate borrowings of $2,085,200, fully funded as of the signing date, with interest at 10% per annum and conversion into common stock.50d ago